3. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology. 2001; 34:1225–1241. PMID:
11732013.
4. Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. Plos One. 2014; 9:e94528. PMID:
24714490.
5. Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J. 2011; 8:513. PMID:
22074048.
6. Schmidt M, Nübling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, et al. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol. 2016; 3:e000067.
7. Shobokshi OA, Serebour FE, Skakni L. Hepatitis B surface gene mutants and their emerging role in the efficacy of HBV vaccination programs. Ann Saudi Med. 1999; 19:87–92. PMID:
17337941.
8. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in Eastern Saudi Arabia, 1998-2001. Clin Lab Haematol. 2004; 26:225–228. PMID:
15163322.
9. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004; 25:26–33. PMID:
14758374.
10. El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, Northwestern Saudi Arabia. Int J Infect Dis. 2008; 12:495–499. PMID:
18400539.
11. Xiao X, Zhai J, Zeng J, Tian C, Wu H, Yu Y. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System. J Virol Methods. 2013; 187:357–361. PMID:
23142222.
12. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004; 86:83–91. PMID:
15023176.
13. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008; 18:55–61. PMID:
18279193.
14. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol. 2001; 64:312–319. PMID:
11424120.
15. Kurdi M, Abughararah M, Mulike M, Yamani O, Bugdady M, Noor M. Molecular detection of hepatitis B virus (HBV) among voluntary ELISA positive blood donors in Almadinah Almunawwarah. J Taibah Univ Med Sci. 2014; 9:166–170.
16. El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, Northwestern Saudi Arabia. Int J Infect Dis. 2008; 12:495–499. PMID:
18400539.
17. Mohammed Abdullah S. Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia. Malays J Med Sci. 2013; 20:41–46. PMID:
23983576.
18. Mahaba HM, El-Tayeb Ael K, El-Sekibi DK, El Gofaei AF, El-Baz HS, Ismail NA. Pattern of HBsAg positivity in selected groups at King Khalid General Hospital-Hail region, Kingdom of Saudi Arabia. J Family Community Med. 1997; 4:30–36. PMID:
23008563.
19. Mahoney FJ, Woodruff BA, Erben JJ, Coleman PJ, Reid EC, Schatz GC, et al. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. J Infect Dis. 1993; 167:203–207. PMID:
8418167.
20. Ramia S, Ramlawi F, Kanaan M, Klayme S, Naman R. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiol Infect. 2005; 133:695–699. PMID:
16050516.
21. Kaminski G, Alnaqdy A, Al-Belushi I, Nograles J, Al-Dhahry SH. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study. Med Princ Pract. 2006; 15:368–372. PMID:
16888395.
22. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res. 2006; 123:37–42. PMID:
16567866.
23. Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Prevalence of antibody to hepatitis B core antigen and hepatitis B virus DNA in HBsAg negative healthy blood donors. Virol J. 2016; 13:36. PMID:
26944046.
24. Badrawy H, Bakry R. Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen. Am J Mol Biol. 2013; 3:62–66.
25. Zekri AR, Awlia AA, El Mahalawi H, Ismail EF, Mabrouk GM. Evaluation of blood units with isolated anti HBC for the presence of HBV DNA. Dis Markers. 2002; 18:107–110. PMID:
12515905.
26. Bodhiphala P, Chaturachumroenchai S, Chiewsilp P, Pruksananonda P. Detection of HBV genome by gene amplification method in HBsAg negative blood donors. J Med Assoc Thai. 1999; 82:491–495. PMID:
10443099.
27. Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007; 18:571–575. PMID:
18054706.
28. Arabaci F, Oldacay M. Investigation of mutant hepatitis B virus in core antibody seropositive cases of blood donor population. J Med Sci. 2008; 8:316–320.
29. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001; 41:652–658. PMID:
11346702.
30. Schmidt M, Nübling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang. 2006; 91:237–243. PMID:
16958836.
31. Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res. 2010; 132:312–317. PMID:
20847378.
32. Said ZN, Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, et al. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013; 5:64–73. PMID:
23646231.
33. Mahmoud OA, Ghazal AA, Del Metwally S, Elnour AM, Yousif GE. Detection of occult hepatitis B virus infection among blood donors in Sudan. J Egypt Public Health Assoc. 2013; 88:14–18. PMID:
23528527.
34. Aljarbou AN. The emergent concern of hepatitis B globally with special attention to Kingdom of Saudi Arabia. Int J Health Sci (Qassim). 2013; 7:333–340. PMID:
24533027.